Liquid Biopsy in Non-Oncological Disorders: Emerging Paradigms and Translational Challenges

This dataset compiles the supporting information and evidence base for the comprehensive review entitled "Liquid Biopsy in Non-Oncological Disorders: Emerging Paradigms and Translational Challenges".

What data contains:
The dataset includes curated literature analysis, synthesized summary tables of key liquid biopsy biomarkers (such as cell-free DNA, extracellular vesicles, and proteins), and their emerging clinical applications across various medical specialties. These specialties include Cardiology, Neurology, Autoimmunity, Infectious Diseases, and Perinatology.

How data was gathered:
The data were systematically gathered from published peer-reviewed literature. The process involved identifying relevant studies, extracting key findings on biomarker performance (e.g., correlation coefficients, predictive values), and organizing them into a structured format to facilitate the analysis presented in the review.

Why this data is valuable:
This structured dataset provides the empirical foundation for the review's conclusions regarding the transformative potential of liquid biopsy in non-cancer diseases. It enables transparency, reproducibility, and serves as a valuable resource for researchers and clinicians seeking to understand the current evidence landscape. It highlights the utility of liquid biopsy for early diagnosis, dynamic monitoring, and prognostic assessment in a wide spectrum of non-malignant conditions.